Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-07 · accession 0001104659-23-030706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-09 | 2023-03-07 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $44.23 | -13.7K | 268.3K | -5% | -$604.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | F | D | 9,397 | $44.23 | 272,560 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-07 | F | D | 4,265 | $44.23 | 268,295 | D | — | — |